drugset / Trial / NCT01871857

7% Hypertonic Saline for Acute Bronchiolitis

NCT01871857

Phase 4 Completed 101 enrolled Le Bonheur Children's Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Research suggests that hypertonic saline may improve mucous flow in infants with acute bronchiolitis. Data suggest a trend favoring reduced length of hospital stay and improved pulmonary scores with increasing concentration of nebulized solution to 3% and 5% saline as compared to 0.9% saline mixed with epinephrine. To our knowledge, 7% hypertonic saline has not been previously investigated. OUr hypothesis was that 7% hypertonic saline would improve bronchiolitis severity scores and admission rate.

Timeline

Start
2010-11
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Hypertonic saline Unknown 3 ml Inhaled
Comparator sodium chloride Unknown 3 ml Inhaled
Comparator Epinephrine Other / unclassified 0.5 ml Inhaled

Indications